Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CHOLESTEROL REDUCTION' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 82 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Dupuis, J
      Mechanisms of acute coronary syndromes and the potential role of statins

      ATHEROSCLEROSIS SUPPLEMENTS
    2. John, S; Delles, C; Jacobi, J; Schlaich, MP; Schneider, M; Schmitz, G; Schmieder, RE
      Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    3. Vaughan, CJ; Delanty, N; Basson, CT
      Statin therapy and stroke prevention

      CURRENT OPINION IN CARDIOLOGY
    4. Meco, JF; Vila, R; Pujol, R; Bros, R; Domenech, P; Fiol, C; Pinto, X
      Improvement in endothelial dysfunction in patients with hypoalphalipoproteinemia and coronary artery disease treated with bezafibrate

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    5. Schwartz, GG; Olsson, AG; Ezekowitz, MD; Ganz, P; Oliver, MF; Waters, D; Zeiher, A; Chaitman, BR; Leslie, S; Stern, T
      Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes - The MIRACL study: A randomized controlled trial

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    6. Dupuis, J
      Mechanisms of acute coronary syndromes and the potential role of statins

      ATHEROSCLEROSIS
    7. Schettler, V; Monazahian, M; Wieland, E; Ramadori, G; Grunewald, RW; Thomssen, R; Muller, GA
      Reduction of hepatitis C virus load by HELP-LDL apheresis

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    8. Maruyama, N; Adachi, M; Takahashi, K; Yagasaki, K; Kohno, M; Takenaka, Y; Okuda, E; Nakagawa, S; Mikami, B; Utsumi, S
      Crystal structures of recombinant and native soybean beta-conglycinin betahomotrimers

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    9. Osseby, GV; Manceau, E; Lemesle-Martin, M; Thomas, V; Giroud, M
      Statins and stroke

      ANNALES D ENDOCRINOLOGIE
    10. Spacil, J; Ceska, R; Haas, T
      Flow-dependent vasomotor dysfunction of the popliteal artery related to common carotid artery intima-media thickness

      ANGIOLOGY
    11. Wangen, KE; Duncan, AM; Xu, X; Kurzer, MS
      Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    12. Waters, DD
      Early pharmacologic intervention and plaque stability in acute coronary syndromes

      AMERICAN JOURNAL OF CARDIOLOGY
    13. Rao, P; Kumar, SU; Rao, DN; Divakar, S
      Optimization of digestion parameters for the elimination of residual beta-cyclodextrin used for cholesterol reduction in egg using glucoamylase

      EUROPEAN FOOD RESEARCH AND TECHNOLOGY
    14. Rosenson, RS
      Biological basis for statin therapy in stroke prevention

      CURRENT OPINION IN NEUROLOGY
    15. Lacombe, S; Theodorou-Bayle, V; La Droitte, P; Dayde, J
      Soya isoflavonoids in the health food chain

      OCL-OLEAGINEUX CORPS GRAS LIPIDES
    16. Kureishi, Y; Luo, ZY; Shiojima, I; Bialik, A; Fulton, D; Lefer, DJ; Sessa, WC; Walsh, K
      The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.

      NATURE MEDICINE
    17. Lazovich, D; Curry, SJ; Beresford, SAA; Kristal, AR; Wagner, EH
      Implementing a dietary intervention in primary care practice: A process evaluation

      AMERICAN JOURNAL OF HEALTH PROMOTION
    18. De Sutter, J; Tavernier, R; De Buyzere, M; Jordaens, L; De Backer, G
      Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    19. Matsuo, M
      Plasma cholesterol reduction by defatted soy ontjom (fermented with Neurospora intermedia) in rats fed a cholesterol-free diet

      JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
    20. Schachinger, V; Zeiher, AM
      Atherosclerosis-associated endothelial dysfunction

      ZEITSCHRIFT FUR KARDIOLOGIE
    21. McCreary, AC; Handley, SL
      Chronic administration of the cholesterol reducing drug gemfibrozil fails to alter 5-HT1A and 5-HT2A mediated receptor behaviours in rats

      JOURNAL OF PSYCHOPHARMACOLOGY
    22. Tonkin, AM; Colquhoun, D; Emberson, J; Hague, W; Keech, A; Lane, G; MacMahon, S; Shaw, J; Simes, RJ; Thompson, PL; White, HD; Hunt, D
      Effects of pravastatin in 3260 patients with unstable angina: results fromthe LIPID study

      LANCET
    23. Laufs, U; Gertz, K; Huang, P; Nickenig, G; Bohm, M; Dirnagl, U; Endres, M
      Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice

      STROKE
    24. Di Garbo, V; Bono, M; Di Raimondo, D; De Simone, R; Raneli, G; Avellone, G
      Non lipid, dose-dependent effects of pravastatin treatment on hemostatic system and inflammatory response

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    25. Epstein, RS
      Responsiveness in quality-of-life assessment - Nomenclature, determinants,and clinical applications

      MEDICAL CARE
    26. Peluso, MR; Winters, TA; Shanahan, MF; Banz, WJ
      A cooperative interaction between soy protein and its isoflavone-enriched fraction lowers hepatic lipids in male obese Zucker rats and reduces blood platelet sensitivity in male Sprague-Dawley rats

      JOURNAL OF NUTRITION
    27. Sirtori, CR; Calabresi, L; Marchioli, R; Rubins, HB
      Cardiovascular risk changes after lipid lowering medications: are they predictable?

      ATHEROSCLEROSIS
    28. Kinlay, S; Ganz, P
      Relation between endothelial dysfunction and the acute coronary syndrome: Implication for therapy

      AMERICAN JOURNAL OF CARDIOLOGY
    29. Bruckert, E
      Caring for hyperlipidic patients as preventive therapy

      OCL-OLEAGINEUX CORPS GRAS LIPIDES
    30. Revicki, DA; Frank, L
      Pharmacoeconomic evaluation in the real world - Effectiveness versus efficacy studies

      PHARMACOECONOMICS
    31. Braeckman, L; De Bacquer, D; Maes, L; De Backer, G
      Effects of a low-intensity worksite-based nutrition intervention

      OCCUPATIONAL MEDICINE-OXFORD
    32. Yeo, KR; Yeo, WW; Wallis, EJ; Ramsay, LE
      Enhanced cholesterol reduction by simvastatin in diltiazem-treated patients

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    33. Cobos, A; Jovell, AJ; Garcia-Altes, A; Garcia-Closas, R; Serra-Majem, L
      Which statin is most efficient for the treatment of hypercholesterolemia? A cost effectiveness analysis

      CLINICAL THERAPEUTICS
    34. Psaty, BM; Weiss, NS; Furberg, CD; Koepsell, TD; Siscovick, DS; Rosendaal, FR; Smith, NL; Heckbert, SR; Kaplan, RC; Lin, DY; Fleming, TR; Wagner, EH
      Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    35. Ahn, J; Kwak, HS
      Optimizing cholesterol removal in cream using beta-cyclodextrin and response surface methodology

      JOURNAL OF FOOD SCIENCE
    36. Suzuki, H; Aoki, T; Tamaki, T; Sato, F; Kitahara, M; Saito, Y
      Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs

      ATHEROSCLEROSIS
    37. O'Toole, DK
      Characteristics and use of okara, the soybean residue from soy milk production - A review

      JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
    38. Wakabayashi, Y
      Effect of red wine consumption on low-density lipoprotein oxidation and atherosclerosis in aorta and coronary artery in Watanabe heritable hyperlipidemic rabbits

      JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
    39. Ockene, IS; Hebert, JR; Ockene, JK; Saperia, GM; Stanek, E; Nicolosi, R; Merriam, PA; Hurley, TG
      Effect of physician-delivered nutrition counseling training and an office-support program on saturated fat intake, weight, and serum lipid measurements in a hyperlipidemic population - Worcester Area Trial for Counseling in Hyperlipidemia (WATCH)

      ARCHIVES OF INTERNAL MEDICINE
    40. Anderson, JW; Smith, BM; Washnock, CS
      Cardiovascular and renal benefits of dry bean and soybean intake

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    41. Olendzki, B; Hurley, TG; Hebert, JR; Ellis, S; Merriam, PA; Luippold, R; Rider, L; Ockene, IS
      Comparing food intake using the Dietary Risk Assessment with multiple 24-hour dietary recalls and the 7-Day Dietary Recall

      JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION
    42. COYLE D; LEE KM
      THE PROBLEM OF PROTOCOL DRIVEN COSTS IN PHARMACOECONOMIC ANALYSIS

      PharmacoEconomics
    43. GEPPERT A; GRAF S; BECKMANN R; HORNYKEWYCZ S; SCHUSTER E; BINDER BR; HUBER K
      CONCENTRATION OF ENDOGENOUS TPA ANTIGEN IN CORONARY-ARTERY DISEASE - RELATION TO THROMBOTIC EVENTS, ASPIRIN TREATMENT, HYPERLIPIDEMIA, AND MULTIVESSEL DISEASE

      Arteriosclerosis, thrombosis, and vascular biology
    44. WHEELER DC
      STATINS AND THE KIDNEY

      Current opinion in nephrology and hypertension
    45. AVORN J; MONETTE J; LACOUR A; BOHN RL; MONANE M; MOGUN H; LELORIER J
      PERSISTENCE OF USE OF LIPID-LOWERING MEDICATIONS - A CROSS-NATIONAL-STUDY

      JAMA, the journal of the American Medical Association
    46. KOSTNER KM; KOSTNER GM
      CHOLESTEROL-REDUCTION 1998 - COMPARISON OF DIFFERENT STATINS

      Wiener Klinische Wochenschrift
    47. MENCHACA HJ; MICHALEK VN; ROHDE TD; ODEA TJ; BUCHWALD H
      DECREASED BLOOD-OXYGEN DIFFUSION IN HYPERCHOLESTEROLEMIA

      Surgery
    48. LICHTENSTEIN AH
      SOY PROTEIN, ISOFLAVONES AND CARDIOVASCULAR-DISEASE RISK

      The Journal of nutrition
    49. SATTAR N; PETRIE JR; JAAP AJ
      THE ATHEROGENIC LIPOPROTEIN PHENOTYPE AND VASCULAR ENDOTHELIAL DYSFUNCTION

      Atherosclerosis (Amsterdam)
    50. WHEELER DC
      ARE THERE POTENTIAL NON-LIPID-LOWERING USES OF STATINS

      Drugs
    51. GROVER SA; PAQUET S; LEVINTON C; COUPAL L; ZOWALL H
      ESTIMATING THE BENEFITS OF MODIFYING RISK-FACTORS OF CARDIOVASCULAR-DISEASE - A COMPARISON OF PRIMARY VS SECONDARY PREVENTION

      Archives of internal medicine
    52. JACOBSON TA; SCHEIN JR; WILLIAMSON A; BALLANTYNE CM
      MAXIMIZING THE COST-EFFECTIVENESS OF LIPID-LOWERING THERAPY

      Archives of internal medicine
    53. FRUCHART JC; BREWER B; LEITERSDORF E; BROCHIER M; BROWN G; CALVO C; CARMENA R; CESKA R; LOYSOONG WC; DAVIGNON J; GOTTO A; GRUNDY S; HAMSTEN A; KEECH A; MATSUZAWA Y; PATCH JR; PAOLETTI R; RASLOVA K; SMIRNOV V; STEINER G; THOMPSON G; ZHU JR
      CONSENSUS FOR THE USE OF FIBRATES IN THE TREATMENT OF DYSLIPOPROTEINEMIA AND CORONARY HEART-DISEASE

      The American journal of cardiology
    54. MICHENER JL
      NUTRITION, EDUCATION, AND FAMILY PHYSICIANS

      Archives of family medicine
    55. HOLME I
      IMPROVED TARGETING OF PRIMARY PREVENTION AFTER WOSCOPS

      NMCD. Nutrition Metabolism and Cardiovascular Diseases
    56. LESCHKE M; SCHOEBEL FC; JAX TW; SCHANNWELL CM; MARX R; STRAUER BE
      LONG-TERM UROKINASE TREATMENT IN END-STAGE CORONARY-ARTERY DISEASE

      Herz
    57. LENNERNAS H; FAGER G
      PHARMACODYNAMICS AND PHARMACOKINETICS OF THE HMG-COA REDUCTASE INHIBITORS - SIMILARITIES AND DIFFERENCES

      Clinical pharmacokinetics
    58. GORELICK PB
      STROKE PREVENTION - WINDOWS OF OPPORTUNITY AND FAILED EXPECTATIONS - A DISCUSSION OF MODIFIABLE CARDIOVASCULAR RISK-FACTORS AND A PREVENTION PROPOSAL

      Neuroepidemiology
    59. HUNZIKER P; BERTEL O
      SECONDARY PREVENTION IN PATIENTS WITH KNO WN CORONARY-ARTERY DISEASE

      Schweizerische medizinische Wochenschrift
    60. MCCRINDLE BW; ONEILL MB; CULLENDEAN G; HELDEN E
      ACCEPTABILITY AND COMPLIANCE WITH 2 FORMS OF CHOLESTYRAMINE IN THE TREATMENT OF HYPERCHOLESTEROLEMIA IN CHILDREN - A RANDOMIZED, CROSSOVER TRIAL

      The Journal of pediatrics
    61. LAUFS U; LAFATA V; LIAO JK
      INHIBITION OF 3-HYDROXY-3-METHYLGLUTARYL (HMG)-COA REDUCTASE BLOCKS HYPOXIA-MEDIATED DOWN-REGULATION OF ENDOTHELIAL NITRIC-OXIDE SYNTHASE

      The Journal of biological chemistry
    62. VANHORN L
      FIBER, LIPIDS, AND CORONARY HEART-DISEASE - A STATEMENT FOR HEALTH-CARE PROFESSIONALS FROM THE NUTRITION COMMITTEE, AMERICAN-HEART-ASSOCIATION

      Circulation
    63. LAUFS U; BOHM M; LIAO JK
      NEW FINDINGS ON THE ACTION OF 3-HYDROXY-3 -METHYLGLUTARYL COENZYME-A REDUCTASE (HMG-COA-REDUCTASE) INHIBITORS

      Deutsche Medizinische Wochenschrift
    64. MCGILL HC
      NUTRITION AND CORONARY HEART-DISEASE IN THE ELDERLY - LOW-FAT OR LAISSEZ-FAIRE

      Nutrition
    65. DAVIS BR; CUTLER JA; GORDON DJ; FURBERG CD; WRIGHT JT; CUSHMAN WC; GRIMM RH; LAROSA J; WHELTON PK; PERRY HM; ALDERMAN MH; FORD CE; OPARIL S; FRANCIS C; PROSCHAN M; PRESSEL S; BLACK HR; HAWKINS CM
      RATIONALE AND DESIGN FOR THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART-ATTACK TRIAL (ALLHAT)

      American journal of hypertension
    66. OCKENE IS; HEBERT JR; OCKENE JK; MERRIAM PA; HURLEY TG; SAPERIA GM
      EFFECT OF TRAINING AND A STRUCTURED OFFICE PRACTICE ON PHYSICIAN DELIVERED NUTRITION COUNSELING - THE WORCESTER-AREA TRIAL FOR COUNSELING IN HYPERLIPIDEMIA (WATCH)

      American journal of preventive medicine
    67. BRESTRICH M; CLAUS J; BLUMCHEN G
      LACTOVEGETARIAN DIET - INFLUENCE ON WEIGH T, LIPIDS, FIBRINOGEN AND LIPOPROTEIN (A) OF HEART-PATIENTS IN THE COURSE OF THEIR CLINICAL REHABILITATION

      Zeitschrift fur Kardiologie
    68. GARDEN AS; DIVER MJ; FRASER WD
      UNDIAGNOSED MORBIDITY IN ADULT WOMEN WITH TURNERS-SYNDROME

      Clinical endocrinology
    69. REN DW; LI L; SCHWABACHER AW; YOUNG JW; BEITZ DC
      MECHANISM OF CHOLESTEROL REDUCTION TO COPROSTANOL BY EUBACTERIUM-COPROSTANOLIGENES ATCC-51222

      Steroids
    70. ELLING JL; DUNCAN SE
      PHYSICAL-PROPERTIES OF 20-PERCENT MILK-FAT REFORMULATED CREAMS MANUFACTURED FROM CHOLESTEROL-REDUCED BUTTEROIL

      Journal of food science
    71. TANIGUCHI S; YANASE T; KOBAYASHI K; TAKAYANAGI R; NAWATA H
      DEHYDROEPIANDROSTERONE MARKEDLY INHIBITS THE ACCUMULATION OF CHOLESTERYL ESTER IN MOUSE MACROPHAGE J774-1 CELLS

      Atherosclerosis
    72. SHIOMI M; ITO T; TSUKADA T; YATA T; WATANABE Y; TSUJITA Y; FUKAMI M; FUKUSHIGE J; HOSOKAWA T; TAMURA A
      REDUCTION OF SERUM-CHOLESTEROL LEVELS ALTERS LESIONAL COMPOSITION OF ATHEROSCLEROTIC PLAQUES - EFFECT OF PRAVASTATIN SODIUM ON ATHEROSCLEROSIS IN MATURE WHHL RABBITS

      Arteriosclerosis, thrombosis, and vascular biology
    73. HARTMAN TJ; HIMES JH; MCCARTHY PR; KUSHI LH
      EFFECTS OF A LOW-FAT, WORKSITE INTERVENTION ON BLOOD-LIPIDS AND LIPOPROTEINS

      Journal of occupational and environmental medicine
    74. DAVIES MG; KLYACHKIN ML; KIM JH; SVENDSEN E; HAGEN PO
      PROLONGED HYPERCHOLESTEROLEMIA INDUCES REVERSIBLE ALTERATIONS IN VENOUS VASOMOTOR FUNCTION

      Journal of investigative surgery
    75. SHEPHERD J
      FIBRATES AND STATINS IN THE TREATMENT OF HYPERLIPIDEMIA - AN APPRAISAL OF THEIR EFFICACY AND SAFETY

      European heart journal
    76. OCKENE JK; OCKENE IS; QUIRK ME; HEBERT JR; SAPERIA GM; LUIPPOLD RS; MERRIAM PA; ELLIS S
      PHYSICIAN TRAINING FOR PATIENT-CENTERED NUTRITION COUNSELING IN A LIPID INTERVENTION TRIAL

      Preventive medicine
    77. STEWART DL; DEFORGE BR; REESECARTER S; PECUKONIS EV; ROBERTS H
      KNOWLEDGE OF BLOOD CHOLESTEROL REDUCTION IN COMMUNITY RESIDENTS

      Journal of the National Medical Association
    78. BYINGTON RP; JUKEMA JW; SALONEN JT; PITT B; BRUSCHKE AV; HOEN H; FURBERG CD; MANCINI J
      REDUCTION IN CARDIOVASCULAR EVENTS DURING PRAVASTATIN THERAPY - POOLED ANALYSIS OF CLINICAL EVENTS OF THE PRAVASTATIN ATHEROSCLEROSIS INTERVENTION PROGRAM

      Circulation
    79. FURRER H; GRANZER E; WAGNER R
      A NEW CLASS OF POTENT HYPOLIPEMIC AGENTS RAISING HIGH-DENSITY-LIPOPROTEINS - SYNTHESIS, REACTIONS AND PHARMACOLOGICAL PROPERTIES

      European journal of medicinal chemistry
    80. YUDKIN JS
      HOW CAN WE BEST PROLONG LIFE - BENEFITS OF CORONARY RISK FACTOR REDUCTION IN NONDIABETIC AND DIABETIC SUBJECTS

      BMJ. British medical journal
    81. DUMONT JM
      EFFECT OF CHOLESTEROL REDUCTION BY SIMVASTATIN ON PROGRESSION OF CORONARY ATHEROSCLEROSIS - DESIGN, BASE-LINE CHARACTERISTICS, AND PROGRESSOF THE MULTICENTER ANTI-ATHEROMA STUDY (MAAS)

      Controlled clinical trials
    82. BOURDREAU A; ARUL J
      CHOLESTEROL REDUCTION AND FAT FRACTIONATION TECHNOLOGIES FOR MILK-FAT- AN OVERVIEW

      Journal of dairy science


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/01/21 alle ore 04:55:42